{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:41:11Z","timestamp":1791650471380,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34014-2","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:40:07Z","timestamp":1769679607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiology and prevention of HPV-driven cervical cancer in urban\u2013rural China: a population-based study of 60,280 women"],"prefix":"10.1038","volume":"16","author":[{"given":"Lizhen","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiying","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"34014_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/IJC.35369","volume":"157","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer. Int. J. Cancer 157, 288\u2013297. https:\/\/doi.org\/10.1002\/IJC.35369 (2025).","journal-title":"Int. J. Cancer"},{"key":"34014_CR2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"34014_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30482-6","author":"M Arbyn","year":"2020","unstructured":"Arbyn, M. et al. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob. Health https:\/\/doi.org\/10.1016\/S2214-109X(19)30482-6 (2020).","journal-title":"Lancet Glob. Health"},{"key":"34014_CR4","unstructured":"WHO. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (HPV). 2021."},{"key":"34014_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/CAM4.70148","volume":"13","author":"B Mo","year":"2024","unstructured":"Mo, B. et al. Prevalence and genotype distribution of HPV combined with cervical pathological results in women from Sichuan, China: A cross-sectional study based on post-vaccination period 2019 to 2023. Cancer Med. 13, e70148. https:\/\/doi.org\/10.1002\/CAM4.70148 (2024).","journal-title":"Cancer Med."},{"key":"34014_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12905-023-02166-W\/FIGURES\/2","volume":"23","author":"H Luan","year":"2023","unstructured":"Luan, H. Human papilloma virus infection and its associated risk for cervical lesions: A cross-sectional study in Putuo area of Shanghai, China. BMC Womens Health 23, 1\u20137. https:\/\/doi.org\/10.1186\/S12905-023-02166-W\/FIGURES\/2 (2023).","journal-title":"BMC Womens Health"},{"key":"34014_CR7","first-page":"90","volume":"30","author":"X Sun","year":"2024","unstructured":"Sun, X. & Sun, X. Epidemiological survey and risk factor analysis of high-risk human papillomavirus in women in Longgang District, Shenzhen. Altern. Ther. Health Med. 30, 90 (2024).","journal-title":"Altern. Ther. Health Med."},{"key":"34014_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013907","author":"X Wen","year":"2019","unstructured":"Wen, X. et al. Urban-rural disparity in cervical cancer in China and feasible interventions for tackling the rural excess. Medicine https:\/\/doi.org\/10.1097\/MD.0000000000013907 (2019).","journal-title":"Medicine"},{"key":"34014_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/RMV.2537","author":"J Wolf","year":"2024","unstructured":"Wolf, J. et al. Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics. Rev. Med. Virol. https:\/\/doi.org\/10.1002\/RMV.2537 (2024).","journal-title":"Rev. Med. Virol."},{"key":"34014_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/S41571-024-00904-Z","volume":"21","author":"T Malag\u00f3n","year":"2024","unstructured":"Malag\u00f3n, T., Franco, E. L., Tejada, R. & Vaccarella, S. Epidemiology of HPV-associated cancers past, present and future: Towards prevention and elimination. Nat. Rev. Clin. Oncol. 21, 522\u2013538. https:\/\/doi.org\/10.1038\/S41571-024-00904-Z (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"34014_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106399","author":"L Bruni","year":"2021","unstructured":"Bruni, L. et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010\u20132019. Prev. Med. https:\/\/doi.org\/10.1016\/j.ypmed.2020.106399 (2021).","journal-title":"Prev. Med."},{"key":"34014_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2399","author":"FC Zhu","year":"2019","unstructured":"Zhu, F. C. et al. Efficacy, immunogenicity and safety of the AS04-HPV-16\/18 vaccine in Chinese women aged 18\u201325 years: End-of-study results from a phase II\/III, randomised, controlled trial. Cancer Med. https:\/\/doi.org\/10.1002\/cam4.2399 (2019).","journal-title":"Cancer Med."},{"key":"34014_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33320","author":"J Bonde","year":"2021","unstructured":"Bonde, J. et al. Methylation markers FAM19A4 and miR124\u20132 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study. Int. J. Cancer https:\/\/doi.org\/10.1002\/ijc.33320 (2021).","journal-title":"Int. J. Cancer"},{"key":"34014_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/VACCINES12070746","author":"M Tobaiqy","year":"2024","unstructured":"Tobaiqy, M. & MacLure, K. A systematic review of human papillomavirus vaccination challenges and strategies to enhance uptake. Vaccines https:\/\/doi.org\/10.3390\/VACCINES12070746 (2024).","journal-title":"Vaccines"},{"key":"34014_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25255","author":"B Li","year":"2019","unstructured":"Li, B., Wang, H., Yang, D. & Ma, J. Prevalence and distribution of cervical human papillomavirus genotypes in women with cytological results from Sichuan province. China. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.25255 (2019).","journal-title":"China. J. Med. Virol."},{"key":"34014_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/S12879-017-2328-6","author":"JF Lu","year":"2017","unstructured":"Lu, J. F. et al. Genotype distribution characteristics of multiple human papillomavirus in women from the Taihu River Basin, on the coast of eastern China. BMC Infect. Dis. https:\/\/doi.org\/10.1186\/S12879-017-2328-6 (2017).","journal-title":"BMC Infect. Dis."},{"key":"34014_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-017-4651-7","author":"C Wu","year":"2017","unstructured":"Wu, C. et al. Epidemiology of Humanpapilloma virus infection among women in Fujian, China. BMC Public Health https:\/\/doi.org\/10.1186\/s12889-017-4651-7 (2017).","journal-title":"BMC Public Health"},{"key":"34014_CR18","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2008.1223","author":"KN Althoff","year":"2009","unstructured":"Althoff, K. N. et al. Correlates of cervicovaginal human papillomavirus detection in perimenopausal women. J. Womens Health https:\/\/doi.org\/10.1089\/jwh.2008.1223 (2009).","journal-title":"J. Womens Health"},{"key":"34014_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/nrc798","author":"H ZurHausen","year":"2002","unstructured":"ZurHausen, H. Papillomaviruses and cancer: From basic studies to clinical application. Nat. Rev. Cancer https:\/\/doi.org\/10.1038\/nrc798 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"34014_CR20","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2013.1350","author":"S Andersson","year":"2013","unstructured":"Andersson, S., Mints, M. & Wilander, E. Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ. Oncol. Lett. https:\/\/doi.org\/10.3892\/ol.2013.1350 (2013).","journal-title":"Oncol. Lett."},{"key":"34014_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.083","author":"J Doorbar","year":"2012","unstructured":"Doorbar, J. et al. The biology and life-cycle of human papillomaviruses. Vaccine https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.083 (2012).","journal-title":"Vaccine"},{"key":"34014_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-004902","author":"WD Kang","year":"2023","unstructured":"Kang, W. D., Ju, U. C. & Kim, S. M. Human papillomavirus genotyping for predicting disease progression in women with biopsy-negative or cervical intraepithelial neoplasia grade 1 of low-grade intraepithelial lesion cytology. Int. J. Gynecol. Cancer https:\/\/doi.org\/10.1136\/ijgc-2023-004902 (2023).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"34014_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/15330338241312573","author":"H Gao","year":"2025","unstructured":"Gao, H. et al. Risk Factors of positive endocervical curettage and predictive model construction based on primary human papillomavirus screening. Technol. Cancer Res. Treat. https:\/\/doi.org\/10.1177\/15330338241312573 (2025).","journal-title":"Technol. Cancer Res. Treat."},{"key":"34014_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/CAC2.12629","volume":"45","author":"M Xu","year":"2025","unstructured":"Xu, M., Cao, C., Wu, P., Huang, X. & Ma, D. Advances in cervical cancer: Current insights and future directions. Cancer Commun. 45, 77\u2013109. https:\/\/doi.org\/10.1002\/CAC2.12629 (2025).","journal-title":"Cancer Commun."},{"key":"34014_CR25","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/HUMREP\/DEAE139","volume":"39","author":"ML Kristensen","year":"2024","unstructured":"Kristensen, M. L. et al. Cervical intraepithelial neoplasia and fecundability: A prospective cohort study. Hum. Reprod. 39, 1835\u20131843. https:\/\/doi.org\/10.1093\/HUMREP\/DEAE139 (2024).","journal-title":"Hum. Reprod."},{"key":"34014_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/BMJOPEN-2018-026413","volume":"9","author":"H Yang","year":"2019","unstructured":"Yang, H., Li, S. P., Chen, Q. & Morgan, C. Barriers to cervical cancer screening among rural women in eastern China: A qualitative study. BMJ Open 9, e026413. https:\/\/doi.org\/10.1136\/BMJOPEN-2018-026413 (2019).","journal-title":"BMJ Open"},{"key":"34014_CR27","doi-asserted-by":"publisher","DOI":"10.7759\/CUREUS.65555","author":"O Farajimakin","year":"2024","unstructured":"Farajimakin, O. Barriers to cervical cancer screening: A systematic review. Cureus. https:\/\/doi.org\/10.7759\/CUREUS.65555 (2024).","journal-title":"Cureus."},{"issue":"1","key":"34014_CR28","doi-asserted-by":"publisher","first-page":"18540","DOI":"10.1038\/s41598-025-02600-z","volume":"15","author":"M Zhang","year":"2025","unstructured":"Zhang, M., Sit, J. W. H., Choi, K. C., Chow, K. M. & Chan, C. W. H. Effects of a theory driven and culturally tailored educational program on promoting cervical cancer screening in rural populations. Sci. Rep. 15(1), 18540. https:\/\/doi.org\/10.1038\/s41598-025-02600-z (2025).","journal-title":"Sci. Rep."},{"key":"34014_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/FPUBH.2022.938272\/BIBTEX","volume":"10","author":"J Li","year":"2022","unstructured":"Li, J, et al. Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening. Front. Public Health. 10, 938272. https:\/\/doi.org\/10.3389\/FPUBH.2022.938272\/BIBTEX (2022).","journal-title":"Front. Public Health."},{"issue":"6","key":"34014_CR30","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1038\/s41591-025-03618-6","volume":"31","author":"Z Hou","year":"2025","unstructured":"Hou, Z. et al. A vaccine chatbot intervention for parents to improve HPV vaccination uptake among middle school girls: A cluster randomized trial. Nat. Med. 31(6), 1855\u20131862. https:\/\/doi.org\/10.1038\/s41591-025-03618-6 (2025).","journal-title":"Nat. Med."},{"key":"34014_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10091911","author":"F Verrier","year":"2021","unstructured":"Verrier, F., Le Coeur, S. & Delory, T. Cervical human papillomavirus infection (Hpv) and high oncogenic risk genotypes among women living with hiv in asia: A meta-analysis. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm10091911 (2021).","journal-title":"J. Clin. Med."},{"key":"34014_CR32","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S69776","author":"S Piris","year":"2014","unstructured":"Piris, S. et al. Natural history of histologically moderate cervical dysplasia in adolescent and young women. Onco Targets Ther. https:\/\/doi.org\/10.2147\/OTT.S69776 (2014).","journal-title":"Onco Targets Ther."},{"key":"34014_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100726","author":"M Shen","year":"2023","unstructured":"Shen, M. et al. Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China. Lancet Reg. Health West Pac. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100726 (2023).","journal-title":"Lancet Reg. Health West Pac."},{"key":"34014_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25331","author":"M Li","year":"2019","unstructured":"Li, M. et al. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.25331 (2019).","journal-title":"J. Med. Virol."},{"key":"34014_CR35","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268821001175","author":"L Chen","year":"2021","unstructured":"Chen, L. et al. The genomic distribution map of human papillomavirus in Western China. Epidemiol. Infect. https:\/\/doi.org\/10.1017\/S0950268821001175 (2021).","journal-title":"Epidemiol. Infect."},{"key":"34014_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30298-3","author":"M Drolet","year":"2019","unstructured":"Drolet, M. et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(19)30298-3 (2019).","journal-title":"Lancet"},{"key":"34014_CR37","doi-asserted-by":"publisher","unstructured":"Luxembourg A, Kjaer SK, Nygard M, Ellison MC, Group T, Marshall JB, et al. Design of a long-term follow-up effectiveness, immunogenicity and safety study of women who received the 9-valent human papillomavirus vaccine. Contemp. Clin. Trials. (2017). https:\/\/doi.org\/10.1016\/j.cct.2016.10.006.","DOI":"10.1016\/j.cct.2016.10.006"},{"key":"34014_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12962-025-00630-Y\/FIGURES\/4","volume":"23","author":"D Zhou","year":"2025","unstructured":"Zhou, D., Zhang, D., Wang, Y., Zhou, K. & Tang, W. Optimizing strategy for cervical cancer prevention in china: A comprehensive modeling analysis. Cost Eff. Resour. Alloc. 23, 1\u201311. https:\/\/doi.org\/10.1186\/S12962-025-00630-Y\/FIGURES\/4 (2025).","journal-title":"Cost Eff. Resour. Alloc."},{"issue":"1","key":"34014_CR39","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1186\/S12889-022-13056-5","volume":"22","author":"L Zhou","year":"2022","unstructured":"Zhou, L., Gu, B., Wang, J., Liu, G. & Zhang, X. Human papillomavirus vaccination at the national and provincial levels in China: A cost-effectiveness analysis using the PRIME model. BMC Public Health 22(1), 777. https:\/\/doi.org\/10.1186\/S12889-022-13056-5 (2022).","journal-title":"BMC Public Health"},{"key":"34014_CR40","unstructured":"Experts promote raising awareness to boost HPV vaccination\u2014Chinadaily.com.cn. https:\/\/www.chinadaily.com.cn\/a\/202511\/05\/WS690b4696a310bfcd27fc5079.html. Accessed 24 Nov 2025."},{"key":"34014_CR41","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/VACCINES13050482","volume":"13","author":"S Zhang","year":"2025","unstructured":"Zhang, S. et al. Overcoming Barriers to human Papillomavirus vaccination in Guangdong province, China. Vaccines 13, 482. https:\/\/doi.org\/10.3390\/VACCINES13050482 (2025).","journal-title":"Vaccines"},{"key":"34014_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22241","author":"S Franceschi","year":"2006","unstructured":"Franceschi, S. et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int. J. Cancer https:\/\/doi.org\/10.1002\/ijc.22241 (2006).","journal-title":"Int. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34014-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34014-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34014-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:40:08Z","timestamp":1769679608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34014-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34014"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34014-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3937"}}